BGI Genomics to hold second extraordinary shareholder meeting in November

BGI Genomics announced its decision to convene the second extraordinary general meeting of shareholders for 2025 on Wednesday, November 12, 2025, at 2:30 PM. The meeting, which will combine on-site voting with online polling, was approved during the seventh meeting of the fourth board of directors. An equity registration date of Thursday, November 6, 2025, has been set for shareholder eligibility.

Key proposals for discussion include amendments to the company's articles of association and revisions to the rules of procedure for shareholder and board meetings. These are classified as special resolutions requiring a two-thirds majority vote. Shareholders will also vote on proposals concerning foreign exchange hedging activities for 2026, and updates to the company’s external guarantee, external investment, and related-party transaction management policies.

Online voting through the Shenzhen Stock Exchange trading system and internet voting system will be available from 9:15 AM to 3:00 PM on the meeting day. Registration for the physical meeting will be open on Monday, November 10, 2025, from 9:30 AM to 11:30 AM and 2:00 PM to 4:30 PM.